Veszprémi B, Halvax L, Csaba I F
Acta Chir Hung. 1987;28(1):27-30.
Priming of uterine cervix with PGF2 alpha has been applied to 253 primigravidae before interruption of first trimester pregnancy. Of them, 140 patients were treated with intracervical PGF2 alpha, while 113 other patients with extraamniotic PGF2 alpha. Spontaneous abortion or complete dilatation occurred in 65% of cases in the first group and in 68% in the second one. Side effects were observed less frequently with intracervical application but no serious complication occurred in either of the groups. Intracervical application of PGF2 alpha gel is recommended because of its effectiveness and low rate of side-effects.
在中断妊娠早期妊娠之前,已对253例初产妇应用前列腺素F2α(PGF2α)预处理宫颈。其中,140例患者采用宫颈内注射PGF2α治疗,另外113例患者采用羊膜外注射PGF2α治疗。第一组65%的病例发生自然流产或宫颈完全扩张,第二组为68%。宫颈内给药时副作用较少见,但两组均未发生严重并发症。鉴于其有效性和低副作用发生率,推荐宫颈内应用PGF2α凝胶。